Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats

Journal of Psychopharmacology

Volumn 31, Issue 1, 2017, Pages 96-104

  Mahmud, Ashraf ^a   Gallant, Stephanie ^a   Sedki, Firas ^a   D'Cunha, Tracey ^a   Shalev, Uri ^a  

^a Dept of Electrical and Computer Engineering   (Canada)

Author keywords

Cannabidiol; cocaine; progressive ratio; relapse

Indexed keywords

CANNABIDIOL; COCAINE; DIAMORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; ELEVATED PLUS MAZE TEST; MALE; NONHUMAN; RAT; REINFORCEMENT; TASK PERFORMANCE; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME; ADDICTION; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; LONG EVANS RAT; PROCEDURES;

ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CANNABIDIOL; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; CUES; HEROIN; MALE; RATS; RATS, LONG-EVANS; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 85009466276     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881116667706     Document Type: Article

References (39)

1. Aguilar MA, Rodriguez-Arias M, Minarro J, (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59: 253-277.
2. Albertson DN, Schmidt CJ, Kapatos G, et al. (2006) Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology 31: 2304-2312.
3. Badiani A, Belin D, Epstein D, et al. (2011) Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 12: 685-700.
4. Bouton ME, Westbrook RF, Corcoran KA, et al. (2006) Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiat 60: 352-360.
5. Campos AC, Moreira FA, Gomes FV, et al. (2012) Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Phil Trans R Soc Lond B Biol Sci 367: 3364-3378.
6. Childress AR, Mozley PD, McElgin W, et al. (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiat 156: 11-18.
7. Conrad KL, Tseng KY, Uejima JL, et al. (2008) Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454: 118-121.
8. Cruz AP, Frei F, Graeff FG, (1994) Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49: 171-176.
9. de Carvalho CR, Takahashi RN, (2016) Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats. Addict Biol. Epub ahead of print 1 2016. doi: 10.1111/adb.12366.
10. Di Chiara G, Imperato A, (1988) Drugs abused by humans preferentially increase synaptic dopamine transmission concentration in the mesolimbic system of freely moving rats. Proc Nat Acad Sci USA 85: 5274-5278.
11. Dong Z, Cao J, Xu L, (2007) Opiate withdrawal modifies synaptic plasticity in subicular-nucleus accumbens pathway in vivo. Neuroscience 144: 845-854.
12. Fuchs RA, Lasseter HC, Ramirez DR, et al. (2008) Relapse to drug seeking following prolonged abstinence: the role of environmental stimuli. Drug Discov Today Dis Models 5: 251-258.
13. Goeders NE, Smith JE, (1986) Reinforcing properties of cocaine in the medical prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacol Biochem Behav 25: 191-199.
14. Grimm JW, Hope BT, Wise RA, et al. (2001) Incubation of cocaine craving after withdrawal. Nature 412: 141-142.
15. Guimaraes FS, Chiaretti TM, Graeff FG, et al. (1990) Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl) 100: 558-559.
16. Hurd YL, Yoon M, Manini AF, et al. (2015) Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage. Neurotherapeutics 12: 807-815.
17. Izzo AA, Borrelli F, Capasso R, et al. (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30: 515-527.
18. Johnson SW, North RA, (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488.
19. Karila L, Reynaud M, Aubin HJ, et al. (2011) Pharmacological treatments for cocaine dependence: is there something new. Curr Pharm Des 17: 1359-1368.
20. Kathmann M, Flau K, Redmer A, et al. (2006) Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol 372: 354-361.
21. Katsidoni V, Anagnostou I, Panagis G, (2013) Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus. Addict Biol 18: 286-296.
22. Malone DT, Jongejan D, Taylor DA, (2009) Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats. Pharmacol Biochem Behav 93: 91-96.
23. Mechoulam R, Parker LA, Gallily R, (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42: 11S-19S.
24. Mechoulam R, Peters M, Murillo-Rodriguez E, et al. (2007) Cannabidiol-recent advances. Chem Biodivers 4: 1678-1692.
25. Moreira FA, Guimarães FS, (2005) Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. Eur J Pharmacol 512: 199-205.
26. Morgan CJ, Freeman TP, Schafer GL, et al. (2010) Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology 35: 1879-1885.
27. O'Brien CP, McLellan AT, (1996) Myths about the treatment of addiction. Lancet 347: 237-240.
28. Pandolfo P, Silveirinha V, dos Santos-Rodrigues A, et al. (2011) Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum. Eur J Pharmacol 655: 38-45.
29. Panlilio LV, (2011) Stimulant Self-Administration. In: Olmstead MC, (eds) Anim Models Drug Addict. New York: Springer, pp. 57-82.
30. Parker LA, Burton P, Sorge RE, et al. (2004) Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology (Berl) 175: 360-366.
31. Prud'homme M, Cata R, Jutras-Aswad D, (2015) Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Subst Abuse 9: 33-38.
32. Ren Y, Whittard J, Higuera-Matas A, et al. (2009) Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci 29: 14764-14769.
33. Richardson NR, Roberts DC, (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Meth 66: 1-11.
34. Roberts DCS, Loh EA, Vickers G, (1989) Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97: 535-538.
35. Robinson TE, Kolb B, (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47: 33-46.
36. Sedki F, D'Cunha T, Shalev U, (2013) A procedure to study the effect of prolonged food restriction on heroin seeking in abstinent rats. J Vis Exp e50751.
37. Sinha R, Catapano D, O'Malley S, (1999) Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl) 142: 343-351.
38. Wright MJJ, Vandewater SA, Taffe MA, (2013) Cannabidiol attenuates deficits of visuospatial associative memory induced by Delta(9) tetrahydrocannabinol. Br J Pharmacol 170: 1365-1373.
39. Zuardi AW, Shirakawa I, Finkelfarb E, et al. (1982) Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology (Berl) 76: 245-250.